Nektar Therapeutics
NASDAQ:NKTR

Watchlist Manager
Nektar Therapeutics Logo
Nektar Therapeutics
NASDAQ:NKTR
Watchlist
Price: 1.17 USD -8.59% Market Closed
Market Cap: 215.4m USD
Have any thoughts about
Nektar Therapeutics?
Write Note

Gross Margin
Nektar Therapeutics

59.2%
Current
71%
Average
48.3%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
59.2%
=
Gross Profit
55.2m
/
Revenue
93.1m

Gross Margin Across Competitors

Country US
Market Cap 215.4m USD
Gross Margin
59%
Country JP
Market Cap 776 550.9T JPY
Gross Margin
-3%
Country US
Market Cap 746.8B USD
Gross Margin
81%
Country UK
Market Cap 440.4B GBP
Gross Margin
56%
Country DK
Market Cap 3.3T DKK
Gross Margin
85%
Country US
Market Cap 365.6B USD
Gross Margin
69%
Country US
Market Cap 249.1B USD
Gross Margin
77%
Country CH
Market Cap 208.5B CHF
Gross Margin
73%
Country CH
Market Cap 181.2B CHF
Gross Margin
75%
Country UK
Market Cap 159.6B GBP
Gross Margin
82%
Country IE
Market Cap 146B USD
Gross Margin
68%

Profitability Report

View the profitability report to see the full profitability analysis for Nektar Therapeutics.

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
59.2%
=
Gross Profit
55.2m
/
Revenue
93.1m
What is the Gross Margin of Nektar Therapeutics?

Based on Nektar Therapeutics's most recent financial statements, the company has Gross Margin of 59.2%.